ID   SNU-1196/GR
AC   CVCL_C1L2
DR   Wikidata; Q114313037
RX   PubMed=28883618;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: In situ; Bile duct, common hepatic duct; UBERON=UBERON_0001175.
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5015 ! SNU-1196
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=28883618; DOI=10.1038/s41598-017-11094-3; PMCID=PMC5589721;
RA   Jung, Dawoon E.
RA   Park, Soo Been
RA   Kim, Kahee
RA   Kim, Chanyang
RA   Song, Si Young
RT   "CG200745, an HDAC inhibitor, induces anti-tumour effects in
RT   cholangiocarcinoma cell lines via miRNAs targeting the Hippo
RT   pathway.";
RL   Sci. Rep. 7:10921.1-10921.13(2017).
//